USANA Health Sciences [Part 3]: ‘All Systems Go’ On Valuation

This is part three of a multi-part series on USANA Health Sciences, Inc. (NYSE:USNA). See part one and part two here. USANA valuation Continued from part two: Without even looking at USANA Health Sciences, Inc. (NYSE:USNA)’s valuation, the company has many attractive qualities. Nevertheless, valuation is important and USANA’s valuation is attractive for many different reasons. Firstly, it would appear that USANA is undervalued when compared to the rest of its sector. For example, for full-year 2013, USANA is expected to earn $5.36 per share, analysts then expect the company to earn $5.75 per share for fiscal 2014. This means…